MiR-223 Promotes Tumor Progression via Targeting RhoB in Gastric Cancer

Table 1

Clinicopathologic variables and miR-223 expression in 52 GC patients.

Variable	MiR-223 expression
	High (n = 26)	Low (n = 26)	value
Age
<65	15	9	0.275
≥65	11	17
Gender
Male	20	18	0.412
Female	6	8
Tumor location
Proximal stomach	4	7	0.583
Distal stomach	14	13
Whole stomach	8	6
Tumor size (cm)
<5	7	12	0.398
≥5	19	14
Histology grade
Low	11	8	0.217
Medium	13	15
High	2	3
Regional lymph node metastasis
Negative	11	11	1.00
Positive	15	15
TNM stage
I/II	6	14	0.022
III/IV	20	12
Live metastasis
Negative	19	26	0.004
Positive	7	0
Borrmann type
I	2	3	0.026
II	13	7
III	6	15
IV	5	1